Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

SBI Life Insurance Company - Strong performance, attractive valuations (<2 FY23 P/EV) - ICICI Securities

Posted On: 2021-01-24 22:17:31 (Time Zone: Arizona, USA)


SBI Life (SBLI) reported a robust Q3FY21 with improvement across products (ULIP as well as protection) and distribution (bancassurance/agency) to take 9MFY21 VNB to Rs15.6bn, flat YoY. Management outlook remains strong while revival of ULIPs / credit life, new product launch in protection, and enhanced distribution provide volume as well as margin levers ahead. Maintain BUY.

- Strong increase in bancassurance, protection (individual as well as group) and ULIP in Q3FY21: Q3/9MFY21 bancassurance has grown 8%/(-)10% YoY. Q3/9MFY21 individual protection has grown 100%/41% while group protection has grown from Rs0.9bn in Q1FY21 to Rs1.5bn in Q2FY21 and Rs1.1bn in Q3FY21. In FY21-TD, absolute ULIP APE has risen from Rs6bn in Q1 to Rs16bn in Q2FY21 and Rs24bn in Q3FY21. SBLI distribution increased by 1,000 branches, 16,000 agents and 500 non-SBI bank branches in Q3FY21 compared to Q2FY21. Agency APE grew 39%/(-)10% QoQ/YoY in Q3FY21 while others grew 11%/43% QoQ/YoY in Q3FY21.

- Protection strategy in terms of product/pricing seems to have paid off in Q3FY21. SBLI maintained ~75-80% of TROP in the protection mix with no price hikes taken unlike peers. This strategy has worked well considering that Q3FY21 individual protection grew by 100%/41% in Q3/9MFY21.

- Management outlook remains robust across product categories. Management indicated that credit life volume had become almost flat YoY till Dec'20 and expects growth in the segment by FY21-end. The new pure protection product is expected to be launched in Q4FY21.

- Operating parameters remain on track. Compared to FY20-end, persistency has improved in all but 49th month cohort. 9MFY21 cost ratios ((commission + Opex) / total premiums (including renewals)) now stand at 8.5%.

- Improved product mix leads to flat growth in 9MFY21 VNB (actual tax rate basis) despite 7% YoY decrease in 9MFY21 APE. 9MFY21 VNB stands at Rs15.6bn. Improved product mix and higher volumes have driven 30pbs YoY improvement in VNB margins.

- Revision in operating estimates can provide a positive surprise to VNB by FY21-end. The VNB walk till 9MFY21 continues to have the same assumptions as of FY20-end. As experience improves (persistency, mortality, cost), there is scope for improvement in VNB margins if volumes support in Q4FY21.

- Maintain BUY with a FY23E-based target price of Rs1,223. Basis effective tax rate, the Embedded Value of SBLI is expected to grow from Rs276.4bn in FY20 to Rs441bn in FY23E driven by addition of Rs54bn unwind and Rs57bn of VNB, which has grown from Rs16bn in FY18 to Rs22bn in FY20. VNB margin (basis effective tax) is expected to be 20.5%/ 21.5% / 22.5% in FY21 / 22 / 23. SBLI currently trades at 1.9x FY23E P/EV.

Shares of SBI Life Insurance Company Ltd was last trading in BSE at Rs.861.6 as compared to the previous close of Rs. 879.25. The total number of shares traded during the day was 174279 in over 10248 trades.

The stock hit an intraday high of Rs. 885.45 and intraday low of 838.2. The net turnover during the day was Rs. 150434947.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020